← COLLEGIUM PHARMACEUTICAL, INC COLL
Market Price
$28.25
Market Cap
$913.01M
P/E Ratio
16.33
Revenue (FY 2025)
↑23.6% YoY
$780.57M
3-Yr CAGR: 18.9%
Net Income
↓-9.1% YoY
$62.87M
Net Margin: 8.1%
Free Cash Flow
↑61.1% YoY
$327.58M
FCF Yield: 35.88%
EPS (Diluted)
↓-7.0% YoY
$1.73
Basic: $1.98
Return on Equity
Efficiency
20.8%
ROA: 192.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (COLL)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1.3M | — | $1.1M | $-94.2M | — | $-3.88 | — | $-75.1M | $-75.5M | — |
| FY 2017 | $10.8M | +728.4% | $8.2M | $-74.9M | +20.5% | $-2.47 | +36.3% | $-67.0M | $-68.0M | +10.0% |
| FY 2018 | $280.4M | +2,497.9% | $114.7M | $-39.1M | +47.7% | $-1.19 | +51.8% | $169.4M | $163.9M | +341.0% |
| FY 2019 | $296.7M | +5.8% | $103.0M | $-22.7M | +41.9% | $-0.68 | +42.9% | $27.8M | $21.3M | -87.0% |
| FY 2020 | $310.0M | +4.5% | $179.8M | $26.8M | +217.7% | $0.76 | +211.8% | $93.9M | $88.4M | +314.1% |
| FY 2021 | $276.9M | -10.7% | $150.6M | $71.5M | +167.3% | $1.86 | +144.7% | $103.6M | $101.6M | +15.0% |
| FY 2022 | $463.9M | +67.6% | $209.5M | $-25.0M | -135.0% | $-0.74 | -139.8% | $124.2M | $122.6M | +20.7% |
| FY 2023 | $566.8M | +22.2% | $326.2M | $48.2M | +292.6% | $1.29 | +274.3% | $274.7M | $274.3M | +123.7% |
| FY 2024 | $631.4M | +11.4% | $377.3M | $69.2M | +43.7% | $1.86 | +44.2% | $205.0M | $203.3M | -25.9% |
| FY 2025 | $780.6M | +23.6% | $463.3M | $62.9M | -9.1% | $1.73 | -7.0% | $329.3M | $327.6M | +61.1% |
Valuation
Market Price
$28.25
Market Cap
$913.01M
Enterprise Value
N/A
P/E Ratio
16.33
P/B Ratio
3.04
FCF Yield
35.88%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
59.35%
Operating Margin
23.01%
Net Margin
8.05%
Return on Equity (ROE)
20.84%
Return on Assets (ROA)
192.60%
Asset Turnover
23.91x
Revenue 3-Yr CAGR
18.94%
Financial Health & Liquidity
Current Ratio
0.52
Cash Ratio
3.70
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$231.25M
Total Debt
N/A
Book Value / Share
$9.30
Cash Flow Efficiency
Operating Cash Flow
$329.32M
Capital Expenditures (CapEx)
$1.74M
Free Cash Flow
$327.58M
OCF / Revenue
42.19%
FCF / Revenue
41.97%
FCF 3-Yr CAGR
38.76%
Per Share Metrics
EPS (Diluted)
$1.73
EPS (Basic)
$1.98
Dividends / Share
N/A
Book Value / Share
$9.30
EPS YoY Growth
-6.99%
Balance Sheet (FY 2025)
Total Assets
$32.64M
Total Liabilities
$62.46M
Stockholders' Equity
$301.68M
Current Assets
$32.64M
Current Liabilities
$62.46M